SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-150146
Filing Date
2022-05-13
Accepted
2022-05-13 16:26:49
Documents
12
Period of Report
2022-05-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d339835d8k.htm   iXBRL 8-K 23892
  Complete submission text file 0001193125-22-150146.txt   145418

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA iobt-20220509.xsd EX-101.SCH 2864
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE iobt-20220509_lab.xml EX-101.LAB 17912
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iobt-20220509_pre.xml EX-101.PRE 11240
6 EXTRACTED XBRL INSTANCE DOCUMENT d339835d8k_htm.xml XML 3330
Mailing Address OLE MAALOES VEH 3 COPENHAGEN G7 2200
Business Address OLE MAALOES VEH 3 COPENHAGEN G7 2200 4570702980
IO Biotech, Inc. (Filer) CIK: 0001865494 (see all company filings)

IRS No.: 870909276 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41008 | Film No.: 22923174
SIC: 2834 Pharmaceutical Preparations